Washington (AP) – Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, was named to monitor the health authority’s program for vaccines and biotech medication.
The FDA Commissioner Dr. Marty Makary announced the appointment on Tuesday in a message to the agency’s employees and praised Prasad’s “long and respected history in medicine”.
Prasad is the latest in a number of medical controls and critics of COVID-19 measures to join the Federal Government under President Donald Trump.
In contrast to political roles such as the FDA commissioner, the Job Prasad was traditionally held by an FDA career scientist. His appointment raises recent questions as to whether vaccines and other recent therapies will unnecessarily check the supervisory authorities.
Prasad replaces Dr. Peter Marks, the long -time FDA vaccine leader, who resigned in March after he had conflict with the health minister Robert F. Kennedy Jr. for concerns about the security of vaccinations.
In a social media contribution, Prasad compared markings with “a Boblehead doll that only stamps the consent”.
Last year he told the former Republican presidential candidate Vivek Ramaswamy that the Americans would probably be better in their current form without the FDA.
“If you talk about the FDA 2024, you would probably be better off not to have the FDA,” said Prasad during an appearance in Ramaswamys Podcast.
Professor at the University of California San Francisco is the medical training of prasad in cancer and blood disorders. He became known for the first time among academics for a number of papers in which the evidence of recent cancer therapies was examined.
Studies by Prasad and his colleagues showed that many of the FDA quickly persecuted cancer drugs have never been proven that they improve or expand the patient’s life. Instead, the medication is often approved on the basis of alternative measures, such as the ability to reduce tumors that are assumed to predict their long -term advantages.
The FDA has long defended this practice to accelerate the approval of medication for desperately ill patients.
During the Covid 19 pandemic, Prasad achieved a much wider audience as a critic of mask mandates, closures and movements in order to accelerate the availability of vaccine boosters from Pfizer and Moderna. Many of his views reflect those other Trump, including Makary and National Institutes of Health Director Jay Bhattcharya.
In 2022, Prasad and Makary were co-authors on a newspaper that attacked the recommendation for booster shots among teenagers and teenage adults, especially boys and teenage men. These patients received special attention because early vaccinations showed a higher myocarditis rate, a occasional form of heart inflammation, which is normally subtle.
The paper came to the conclusion that the requirement of booster shots in teenage people would cause more injuries than benefits. None of the authors specialized in examining infectious diseases or vaccine reactions, which caused many health experts to set up.
In recent years, Prasad has been regularly associated with Kennedy’s “Make America Healthy” movement, which the FDA is often committed to in the pharmaceutical industry.
The appointment of Prasad is likely that pharmaceuticals and vaccines are alerted, which depend on the predictability of FDA standards and procedures in order to lead the development plans for the development of medicinal products that can include years or decades.
___
The Department of Health and Science from Associated Press receives support from the Science and Educational Media Group of the Howard Hughes Medical Institute and Robert Wood Johnson Foundation. The AP is only responsible for all content.
